small molecule

VEREGEN

SINECATECHINS

Loss of exclusivityOctober 2026latest FDA-listed patent expiry
CompanyANI PHARMACEUTICALS INC

Drug detail

Brand nameVEREGEN
Active ingredientSINECATECHINS
Strength15%
Dosage formOINTMENT
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 2006
Marketing statusRX

Listed patents

PatentExpiresType
7858662October 2026product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.